Pathophysiology of Tendinopathy


Tendon

Site of tendinopathy

Loading factors

Age/sex

Achilles

Achilles insertion or mid-portion

Distance running, change of direction (combined tensile and compressive load at the calcaneus)

Men—elite and recreational (Jarvinen et al. 2005)

Patellar

Inferior pole of patella

Jumping and landing, fast change of direction, e.g. volleyball

Younger athletes (Cassel et al. 2015)

<30 years old

Proximal hamstring

Ischial attachment of hamstring

Training errors

Sprinting +− bending, e.g. hockey (combined compressive and tensile load)

Any age in an active person (Goom et al. 2016)

Gluteal

Greater trochanter

Stairs and walking

Postmenopausal women (Grimaldi et al. 2015)

Adductor

Adductor tendon or insertion

Kicking

Male athletes (Weir et al. 2015)Kicking sports

Lateral elbow

Common extensor origin

Manual work or gripping tasks, racquet sports (Roquelaure et al. 2006; Descatha et al. 2013)

>40 years old (Bisset and Vicenzino 2015)

Rotator cuff

Sub-acromial

Overhead activity (Seitz et al. 2011)

Young overhead athletes (Sein et al. 2010)

Older than 50 years (Bodin et al. 2012)



The prevalence of tendinopathy may be underestimated as the condition may be mild, and patients may not present for diagnosis and management. This is also seen in a sporting context, where an athlete may continue to train and play with tendinopathy; tendinopathy may not register as an injury as injury statistics are usually recorded when there is a sporting time loss. It is worth noting that the burden is greater than missed participation as the impact on performance is difficult to measure.

Because of the varied definitions, diagnostic criteria, tendon studied and population, estimates of prevalence vary between studies. The general population have a 2–5% prevalence of tendinopathy (across all body sites) (Hopkins et al. 2016), though subgroups such as patellar tendinopathy in volleyball players have rates of up to 40%. Incidence of rotator cuff tendinopathy is estimated as high as 5.5% (Littlewood et al. 2013), while incidence of lateral epicondylalgia is around 1–2% (Gabel 1999; Allander 1974).

Prevalence of tendinopathy in elite sport also is highly dependent on the nature of the sport and thus the loading factors present (Ackermann and Renstrom 2012). Studies in soccer have shown 2.4% prevalence of patellar tendinopathy across a season; median absence from play was only 5 days per injury (Hagglund et al. 2011). An 11% lifetime prevalence of Achilles tendinopathy has been shown in runners (Jarvinen et al. 2005).

Pathology can be identified on imaging, but it may be asymptomatic, highlighting the poor connection between pain and structure (Docking et al. 2015). The presence of tendon pathology in pain-free individuals has been estimated as high as 50% in some populations, such as Australian football (Docking et al. 2015). Pathology on imaging is a risk factor for developing future symptoms (McAuliffe et al. 2016), though the risk is inconsistent across different tendons. In patellar and Achilles tendinopathy, the presence of pathology on greyscale ultrasound increased the risk of developing tendinopathy approximately five times (McAuliffe et al. 2016). Despite these findings, a number of other risk factors are involved in the development of tendinopathy. The majority of those with asymptomatic pathology will not develop symptoms and will never present for medical management; hence, caution in interpreting the importance of imaging abnormalities is required.



3.14 Intrinsic Risk Factors


Intrinsic factors may be modifiable or unmodifiable and relate to a person’s body composition, lifestyle and general health. It is critical to investigate these factors and address systemic contributors for successful management.


3.14.1 Genetics


Genetic factors are implicated in the pathogenesis of tendinopathy. Identical twin studies have implicated genetic factors in lateral epicondylalgia (Hakim et al. 2003). A number of different genes have been found to be upregulated and downregulated in tendinopathy; however their significance is yet to be determined (September et al. 2007; Jelinsky et al. 2011; Magra and Maffulli 2008). Two variants for COL5A1 gene and the tenascin-C (TNC) gene have been implicated in tendon pathology. COL5A1 encodes for a component of Type V collagen, which aligns and organises Type I collagen (Birk et al. 1990). A specific phenotype results in more tightly packed collagen bundles leading to both better energy storage and also greater vulnerability to tendinopathy. Variations in the COL5A1 gene are linked to an increased risk of Achilles tendinopathy (Chauhan et al. 2015; Mokone et al. 2006; September et al. 2009). Tenascin-C is an anti-adhesive protein, which is important in the regulation of load capacity after tendon loading and compression (Jarvinen et al. 2000). Variants of the TNC gene have also been linked with Achilles tendinopathy, with certain polymorphisms increasing the risk of developing symptoms sixfold (Mokone et al. 2005). Polymorphisms within the TNC or COL5A1 gene have been suggested to be linked to other injuries such as ACL tears (September et al. 2007); however so far results have been conflicting (Stepien-Slodkowska et al. 2015; Posthumus et al. 2010).

Other factors involved in tissue repair in tendons include transforming growth factor β1 (TGF-β1) and growth/differentiation factor 5 (GDF-5) (Hou et al. 2009; Rickert et al. 2005). A genetic association study however showed no difference in TGF-β1 expression between people with tendinopathy and controls. Genes coding for GDF-5 however were significantly associated with Achilles tendinopathy, showing a modest two times elevated risk (Posthumus et al. 2010).


3.14.2 Sex


The impact of sex on tendinopathy varies across the population, as well as affecting different tendons. Postmenopausal women exhibit higher rates of tendinopathy (Frizziero et al. 2014) and tendon rupture (Maffulli et al. 2007); however this may be confounded by other factors such as increased blood lipids. There was no impact of gender in Achilles or patellar tendinopathy in masters athletes (Longo et al. 2009, 2011). Peritendon disorders such as De Quervain’s tenosynovitis are more common in women (Wolf et al. 2009), and this may be linked to altered inflammatory responses in women (Hart et al. 1998).


3.14.3 Age


Ageing is thought of as a risk factor for developing degenerative pathology; however ageing alone does not explain tendon pathology. Ageing affects the structure and histology of tendons, with increased stiffness, deformation and cross-sectional area, as well as decreased peak tendon stress and strain (Carroll et al. 2008; Tuite et al. 1997). However, when force is normalised, there is no difference seen between young and old tendons in terms of deformation, strain and stiffness, suggesting change in force-output capacity may be more responsible for the alterations seen during ageing (Carroll et al. 2008). Other studies have shown increase in collagen cross-linking, decrease in water content and collagen concentration (Narici et al. 2008; Couppe et al. 2009), as well as a decrease in blood supply (Tuite et al. 1997). Together it seems that load capacity decreases with age, particularly with reference to energy storage and release loading. Ageing is a risk factor for tendon rupture (Pedowitz and Kirwan 2013), and cumulative loading may also be a factor, as past athletes exhibit higher rates of tendinopathy and rupture (Kujala et al. 2005).

Young athletes exhibit high rates of tendon pathology. In children, tendon pathology may be seen on imaging (Simpson et al. 2016); however pain is commonly attributed to the apophysis (such as Osgood-Schlatters disease). Evidence is however emerging to suggest that tendon pathology may be present in children and adolescents distant to the apophysis (Sailly et al. 2013).


3.14.4 Medications


Fluoroquinolones, a class of antibiotic, have been closely associated with the development of tendinopathy and tendon rupture (Lewis and Cook 2014). The Achilles tendon is the site most commonly affected (Lang et al. 2016; Khaliq and Zhanel 2003). Men appear to be at greater risk, with a dose-dependent response seen (Khaliq and Zhanel 2003; Lewis and Cook 2014). Fluoroquinolones are thought to have their effect by decreasing cell numbers and increasing matrix breakdown. Fluoroquinolone-associated tendinopathy may be slower to respond to treatment (Lewis and Cook 2014).

Statin medications have also been implicated as a risk factor for developing tendinopathy, though evidence is conflicting (Teichtahl et al. 2016; Kirchgesner et al. 2014). A number of case reports show increased incidence of tendinopathy (Kirchgesner et al. 2014; Marie et al. 2008); however a recent systematic review showed no increased risk (Teichtahl et al. 2016). Conversely simvastatin may actually slightly decrease the risk of tendinopathy (Contractor et al. 2015).

Finally local and systemic use of glucocorticoids has been suggested to negatively affect tendon tissue (Dean et al. 2014; Blanco et al. 2005). Local glucocorticoid injection leads to decreased collagen production, impaired cell proliferation, increased matrix disorganisation and hence lower mechanical load tolerance of the tendon cells (Dean et al. 2014). Long-term clinical outcomes were worse following corticosteroid injection in lateral epicondylalgia (Coombes et al. 2016). An association between local injection and rupture has been proposed (Kirchgesner et al. 2014; Blanco et al. 2005); however little evidence supports this (Scott et al. 2015a).


3.14.5 General Health


Obesity is considered a risk factor for a variety of musculoskeletal conditions and has also been shown as a risk factor for developing tendinopathy (Scott et al. 2015b; Gaida et al. 2008, 2009a; Franceschi et al. 2014). Elevated body mass index has been shown in tendinopathy compared to control, though a variety of interactions may be responsible (Scott et al. 2013; Klein et al. 2013; Gaida et al. 2008, 2009a). Increased waist circumference was also linked with asymptomatic tendon pathology. There are differences between fat distributions in men and women; men with tendinopathy have more central adiposity, while women exhibit peripheral distribution of fat (Gaida et al. 2010). This is supported by findings in men showing waist girth over 83 cm was a risk factor for patellar tendinopathy in volleyball players but not in women (Malliaras et al. 2007).

Obesity has both mechanical and systemic effects (Scott et al. 2014). Elevated load on tendons due to excessive weight has been postulated to be behind the elevated risk of tendinopathy. From a systemic viewpoint, obesity increases blood lipids, which have also been shown elevated in Achilles tendinopathy (Gaida et al. 2009b).

Systemic diseases and illnesses associated with obesity can predispose to tendinopathy. People with Type II diabetes mellitus have a 3.6 times greater prevalence of tendinopathy than controls (Ranger et al. 2016). Increased tendon thickness is also reported in diabetes (de Oliveira et al. 2011a). The mechanism may be via hyperglycaemia that reduces proteoglycan content and increased levels of transforming growth factor β1 (TGF-β1) (Burner et al. 2012). Diabetes also leads to increased formation of advanced glycation end products (AGE), which can create more collagen cross-links (Snedeker and Gautieri 2014; Abate et al. 2013; Reddy 2003). Increased AGE content is shown to decrease the viscoelastic properties of tendons, by decreased sliding between fibres (Li et al. 2013; Fessel et al. 2014). Increased cross-linking can increase load to failure (Snedeker and Gautieri 2014) and increase stiffness, while other studies showed greater tissue fragility (Fox et al. 2011; de Oliveira et al. 2011b).

Dyslipidaemia may predispose tendons to pain and pathology by altering tendon structure and increased levels of immune and pro-inflammatory cells (Scott et al. 2014). The dyslipidaemia seen in Achilles tendinopathy is similar to that seen in insulin resistance, and it has been proposed that tendinopathy may be a comorbidity of metabolic syndrome and cardiovascular disease (Gaida et al. 2009b). This may also explain why decreased physical activity is associated with development of tendinopathy (Descatha et al. 2013). Tendon pain then further reduces physical activity.

Hypercholesterolaemia also appears to be associated with tendinopathy (Tilley et al. 2015; Esenkaya and Unay 2011), particularly in familial cases (Abate et al. 2013; Beeharry et al. 2006). Increased blood lipids increase the accumulation of pro-inflammatory cells, mast cells and macrophages, as well as increased deposition of low-density lipoproteins (LDLs) in the tendon matrix (Tilley et al. 2015). Association with lower physical activity levels or other comorbidities may be driving this link (Tilley et al. 2015). A number of other illnesses have been linked with elevated risk for tendinopathy including hyperuricaemia (Abate et al. 2013), systemic lupus, rheumatoid arthritis (Fredberg 1997), psoriatic arthritis (Gutierrez et al. 2010) and hypertension (Holmes and Lin 2006).


3.14.6 Flexibility and Joint Stiffness


Reduced flexibility of muscles attaching to the at-risk tendon as well as antagonist muscle groups has been shown to increase the risk of developing tendinopathy. Both quadriceps and hamstring inflexibility have been shown as a risk factor for development of patellar tendinopathy (Witvrouw et al. 2001; Silva et al. 2016; Crossley et al. 2007; Cook et al. 2002). Too much or too little ankle dorsiflexion range is a risk factor for developing Achilles and patellar tendinopathy (Backman and Danielson 2011; Malliaras et al. 2006; Crossley et al. 2007; Kaufman et al. 1999; Rabin et al. 2014; Mahieu et al. 2006).

There is little evidence that foot posture and mechanics are associated with tendinopathy nor that altering them with orthotics is effective despite widespread clinical use (Munteanu et al. 2015). Static foot posture has not been shown as a risk factor for patellar tendinopathy (de Groot et al. 2012; Crossley et al. 2007). Increased ankle inversion moments during landing and jumping tasks have been associated with patellar tendinopathy (Richards et al. 2002). Excessive foot pronation is often suggested as a risk factor for Achilles tendinopathy (Munteanu and Barton 2011); however quality research beyond anecdotal evidence is lacking (Dowling et al. 2014).


3.14.7 Strength


Clinically, poor strength is often associated with tendinopathy, likely mediated by pain. Decreased eccentric strength has been found in the quadriceps in people with patellar tendinopathy (Gaida et al. 2004) and gastrocnemius in those with Achilles tendinopathy (Silbernagel et al. 2006; Haglund-Akerlind and Eriksson 1993). Functional deficits such as decreased vertical jump and hopping ability (Silbernagel et al. 2006) have also been shown.

However a strength deficit has not been shown prospectively, with no relationship shown between quadriceps and hamstring strength and the development of patellar tendinopathy (Witvrouw et al. 2001). Consideration of kinetic chain deficits is important, as reduced strength in other regions may predispose a tendon to overload, and should be assessed on an individual basis when managing tendinopathy (Malliaras et al. 2015; Kountouris and Cook 2007).


3.15 Extrinsic Risk Factors


Extrinsic risk factors vary for each tendon. Lower limb tendinopathies are seen in weight-bearing sports, while shoulder tendinopathies are seen in overhead sports such as swimming and volleyball. Activities with high energy storage demands pose the highest risk for developing tendinopathy. Common examples of tensile (energy storage) overload include jumping in basketball or volleyball players, uphill running in runners and change of direction and kicking in field sports.


3.15.1 Load


Excessive loading above a tendon’s capacity is a cause of tendinopathy. Clinically, activities requiring energy storage loads (such as running for the Achilles tendon) are associated with onset of tendon pain. While previous terminology has referred to tendinopathy as ‘repetitive strain injuries’, sports with high-frequency cyclical load such as cycling and rowing with low-energy storage components do not have high rates of tendinopathy. The clinician must understand load and use it as part of their differential diagnosis and decision making; the cyclist and rower are vulnerable to paratendinitis due to the repetitive friction in these activities and require different management.

The amount of loading may be critical; female basketball players with patellar tendon pathology trained 2.14 h more each week on average than their pain-free colleagues (Gaida et al. 2004). The number of hours trained significantly correlated with supraspinatus tendinopathy in swimmers (Sein et al. 2010). Training volume, as well as increased game exposure, was also a risk factor for patellar tendinopathy in volleyball players (Visnes and Bahr 2013). These findings are similar to other sports-related injuries, such as in those seen in throwers in baseball (Olsen et al. 2006) and bowlers in cricket (Hulin et al. 2014).

While total load is important, change in loading and training errors are key factors in a number of musculoskeletal pathologies, including tendinopathy. Consideration of the acute versus chronic workloads may be a factor to decrease risk of injury (Gabbett 2016). An optimum amount of loading appears to be protective while excess or insufficient loading precipitating greater risk. Orchard et al. (2015) found that medium-term workload (3 months) was protective for the development of tendon injuries in cricket bowlers. Clinically, tendinopathy presentations are very often seen after changes in training loads (Ferretti 1986). This may be change of training cycle, onset of intensive competitions, and even change in equipment or footwear. It is often common to see increased cases of tendinopathy in the beginning of a season after resumption of training, and this may also relate to underloading in the off-season and a relative increase in load with resumption of training.

While the majority of research concerns tendon overload, offloading or unloading may predispose a tendon to pain and symptoms as it may lower the load capacity, placing an individual at risk of tendinopathy (Kannus et al. 1997). Sedentary individuals are also at risk of developing tendinopathy, when they perform abusive loading or unaccustomed activity (as it exceeds their load capacity). This has been proposed in rotator cuff tendinopathy, often seen in older less active patients (Lewis 2010). Underload may also be seen when an athlete resumes training after a long layoff (such as the off-season) or injury. The importance of load is reinforced by the fact that complete rest of a symptomatic tendon will not cure a patient’s presentation and often leads to a worsening tendinopathy once load is resumed.


References



Abate M, Silbernagel KG, Siljeholm C, Di Iorio A, De Amicis D, Salini V et al (2009) Pathogenesis of tendinopathies: inflammation or degeneration? Arthritis Res Ther 11(3):235. doi:10.​1186/​ar2723 PubMedPubMedCentral


Abate M, Schiavone C, Salini V, Andia I (2013) Occurrence of tendon pathologies in metabolic disorders. Rheumatology (Oxford) 52(4):599–608. doi:10.​1093/​rheumatology/​kes395


Ackermann PW, Renstrom P (2012) Tendinopathy in sport. Sports Health 4(3):193–201. doi:10.​1177/​1941738112440957​ PubMedPubMedCentral


Ackermann PW, Bring DK-I, Renström P (2005) Tendon innervation and neuronal response after injury. In: Maffulli N, Renström P, Leadbetter WB (eds) Tendon injuries: basic science and clinical medicine. Springer, London, pp 287–297


Ahmed IM, Lagopoulos M, McConnell P, Soames RW, Sefton GK (1998) Blood supply of the Achilles tendon. J Orthop Res 16(5):591–596. doi:10.​1002/​jor.​1100160511 PubMed


Alexander RM (2002) Tendon elasticity and muscle function. Comp Biochem Physiol A Mol Integr Physiol 133(4):1001–1011PubMed


Alexander RM, Maloiy GMO, Ker RF, Jayes AS, Warui CN (1982) The role of tendon elasticity in the locomotion of the camel (Camelus-Dromedarius). J Zool 198(November):293–313


Alfredson H, Thorsen K, Lorentzon R (1999) In situ microdialysis in tendon tissue: high levels of glutamate, but not prostaglandin E2 in chronic Achilles tendon pain. Knee Surg Sports Traumatol Arthrosc 7(6):378–381. doi:10.​1007/​s001670050184 PubMed


Alfredson H, Ljung BO, Thorsen K, Lorentzon R (2000) In vivo investigation of ECRB tendons with microdialysis technique—no signs of inflammation but high amounts of glutamate in tennis elbow. Acta Orthop Scand 71(5):475–479. doi:10.​1080/​0001647003173811​62 PubMed


Alfredson H, Forsgren S, Thorsen K, Lorentzon R (2001) In vivo microdialysis and immunohistochemical analyses of tendon tissue demonstrated high amounts of free glutamate and glutamate NMDAR1 receptors, but no signs of inflammation, in Jumper’s knee. J Orthop Res 19(5):881–886. doi:10.​1016/​S0736-0266(01)00016-X PubMed


Alfredson H, Bjur D, Thorsen K, Lorentzon R, Sandstrom P (2002) High intratendinous lactate levels in painful chronic Achilles tendinosis. An investigation using microdialysis technique. J Orthop Res 20(5):934–938. doi:10.​1016/​S0736-0266(02)00021-9 PubMed


Alfredson H, Ohberg L, Forsgren S (2003) Is vasculo-neural ingrowth the cause of pain in chronic Achilles tendinosis? An investigation using ultrasonography and colour Doppler, immunohistochemistry, and diagnostic injections. Knee Surg Sports Traumatol Arthrosc 11(5):334–338. doi:10.​1007/​s00167-003-0391-6 PubMed


Allander E (1974) Prevalence, incidence, and remission rates of some common rheumatic diseases or syndromes. Scand J Rheumatol 3(3):145–153PubMed


Amiel D, Frank C, Harwood F, Fronek J, Akeson W (1984) Tendons and ligaments: a morphological and biochemical comparison. J Orthop Res 1(3):257–265. doi:10.​1002/​jor.​1100010305 PubMed


Andersen MB, Pingel J, Kjaer M, Langberg H (2011) Interleukin-6: a growth factor stimulating collagen synthesis in human tendon. J Appl Physiol (1985) 110(6):1549–1554. doi:10.​1152/​japplphysiol.​00037.​2010


Apostolakos J, Durant TJ, Dwyer CR, Russell RP, Weinreb JH, Alaee F et al (2014) The enthesis: a review of the tendon-to-bone insertion. Muscles Ligaments Tendons J 4(3):333–342PubMedPubMedCentral


Arnoczky SP, Lavagnino M, Egerbacher M (2007) The mechanobiological aetiopathogenesis of tendinopathy: is it the over-stimulation or the under-stimulation of tendon cells? Int J Exp Pathol 88(4):217–226. doi:10.​1111/​j.​1365-2613.​2007.​00548.​x PubMedPubMedCentral


Astrom M, Westlin N (1994) Blood flow in the human Achilles tendon assessed by laser Doppler flowmetry. J Orthop Res 12(2):246–252. doi:10.​1002/​jor.​1100120214 PubMed


Backman LJ, Danielson P (2011) Low range of ankle dorsiflexion predisposes for patellar tendinopathy in junior elite basketball players: a 1-year prospective study. Am J Sports Med 39(12):2626–2633. doi:10.​1177/​0363546511420552​ PubMed


Backman LJ, Andersson G, Wennstig G, Forsgren S, Danielson P (2011a) Endogenous substance P production in the Achilles tendon increases with loading in an in vivo model of tendinopathy-peptidergic elevation preceding tendinosis-like tissue changes. J Musculoskelet Neuronal Interact 11(2):133–140PubMed


Backman LJ, Fong G, Andersson G, Scott A, Danielson P (2011b) Substance P is a mechanoresponsive, autocrine regulator of human tenocyte proliferation. PLoS One 6(11):e27209. doi:10.​1371/​journal.​pone.​0027209 PubMedPubMedCentral


Baldock C, Koster AJ, Ziese U, Rock MJ, Sherratt MJ, Kadler KE et al (2001) The supramolecular organization of fibrillin-rich microfibrils. J Cell Biol 152(5):1045–1056PubMedPubMedCentral


Banes AJ, Weinhold P, Yang X, Tsuzaki M, Bynum D, Bottlang M, Brown T et al (1999) Gap junctions regulate responses of tendon cells ex vivo to mechanical loading. Clin Orthop Relat Res (367 Suppl):S356–S370


Beeharry D, Coupe B, Benbow EW, Morgan J, Kwok S, Charlton-Menys V et al (2006) Familial hypercholesterolaemia commonly presents with Achilles tenosynovitis. Ann Rheum Dis 65(3):312–315. doi:10.​1136/​ard.​2005.​040766 PubMed


Benjamin M, McGonagle D (2001) The anatomical basis for disease localisation in seronegative spondyloarthropathy at entheses and related sites. J Anat 199(Pt 5):503–526PubMedPubMedCentral


Benjamin M, Ralphs JR (1997) Tendons and ligaments—an overview. Histol Histopathol 12(4):1135–1144PubMed


Benjamin M, Ralphs JR (1998) Fibrocartilage in tendons and ligaments—an adaptation to compressive load. J Anat 193(Pt 4):481–494PubMedPubMedCentral


Benjamin M, Evans EJ, Copp L (1986) The histology of tendon attachments to bone in man. J Anat 149:89–100PubMedPubMedCentral


Benjamin M, Toumi H, Ralphs JR, Bydder G, Best TM, Milz S (2006) Where tendons and ligaments meet bone: attachment sites (‘entheses’) in relation to exercise and/or mechanical load. J Anat 208(4):471–490. doi:10.​1111/​j.​1469-7580.​2006.​00540.​x PubMedPubMedCentral


Benjamin M, Kaiser E, Milz S (2008) Structure-function relationships in tendons: a review. J Anat 212(3):211–228. doi:10.​1111/​j.​1469-7580.​2008.​00864.​x PubMedPubMedCentral


Biermann H (1957) Die Knochenbildung im Bereich periostaler-diaphysärer Sehnen- und Bandansätze. Z Zellforsch Mikrosk Anat 46(6):635–671. doi:10.​1007/​BF00339370 PubMed


Birk DE, Fitch JM, Babiarz JP, Doane KJ, Linsenmayer TF (1990) Collagen fibrillogenesis in vitro: interaction of types I and V collagen regulates fibril diameter. J Cell Sci 95(Pt 4):649–657PubMed


Bisset LM, Vicenzino B (2015) Physiotherapy management of lateral epicondylalgia. J Physiother 61(4):174–181. doi:10.​1016/​j.​jphys.​2015.​07.​015 PubMed


Blanco I, Krahenbuhl S, Schlienger RG (2005) Corticosteroid-associated tendinopathies: an analysis of the published literature and spontaneous pharmacovigilance data. Drug Saf 28(7):633–643. doi:10.​2165/​00002018-200528070-00005


Bodin J, Ha C, Petit Le Manac’h A, Serazin C, Descatha A, Leclerc A et al (2012) Risk factors for incidence of rotator cuff syndrome in a large working population. Scand J Work Environ Health 38(5):436–446. doi:10.​5271/​sjweh.​3285 PubMed


Brughelli M, Cronin J (2008) A review of research on the mechanical stiffness in running and jumping: methodology and implications. Scand J Med Sci Sports 18(4):417–426PubMed


Burner T, Gohr C, Mitton-Fitzgerald E, Rosenthal AK (2012) Hyperglycemia reduces proteoglycan levels in tendons. Connect Tissue Res 53(6):535–541. doi:10.​3109/​03008207.​2012.​710670 PubMed


Carroll CC, Dickinson JM, Haus JM, Lee GA, Hollon CJ, Aagaard P et al (2008) Influence of aging on the in vivo properties of human patellar tendon. J Appl Physiol (1985) 105(6):1907–1915. doi:10.​1152/​japplphysiol.​00059.​2008 PubMedCentral


Cassel M, Baur H, Hirschmuller A, Carlsohn A, Frohlich K, Mayer F (2015) Prevalence of Achilles and patellar tendinopathy and their association to intratendinous changes in adolescent athletes. Scand J Med Sci Sports 25(3):e310–e318. doi:10.​1111/​sms.​12318 PubMed


Chauhan AA, Morrissey D, Jones PR, Angioi M, Kumar B, Langberg H et al (2015) Genetic risk factors for mid-portion Achilles tendinopathy: a systematic review. Bone & Joint Journal Orthopaedic Proceedings Supplement, 97-B(SUPP 11), 32


Chen TM, Rozen WM, Pan WR, Ashton MW, Richardson MD, Taylor GI (2009) The arterial anatomy of the Achilles tendon: anatomical study and clinical implications. Clin Anat 22(3):377–385. doi:10.​1002/​ca.​20758 PubMed


Chiquet M, Renedo AS, Huber F, Fluck M (2003) How do fibroblasts translate mechanical signals into changes in extracellular matrix production? Matrix Biol 22(1):73–80PubMed


Contractor T, Beri A, Gardiner JC, Tang X, Dwamena FC (2015) Is statin use associated with tendon rupture? A population-based retrospective cohort analysis. Am J Ther 22(5):377–381. doi:10.​1097/​MJT.​0000000000000039​ PubMed


Cook JL, Purdam CR (2003) Rehabilitation of lower limb tendinopathies. Clin Sports Med 22(4):777–789PubMed


Cook JL, Purdam CR (2009) Is tendon pathology a continuum? A pathology model to explain the clinical presentation of load-induced tendinopathy. Br J Sports Med 43(6):409–416. doi:10.​1136/​bjsm.​2008.​051193 PubMed


Cook JL, Purdam C (2012) Is compressive load a factor in the development of tendinopathy? Br J Sports Med 46(3):163–168. doi:10.​1136/​bjsports-2011-090414 PubMed


Cook JL, Khan KM, Harcourt PR, Kiss ZS, Fehrmann MW, Griffiths L, Wark JD (1998) Patellar tendon ultrasonography in asymptomatic active athletes reveals hypoechoic regions: a study of 320 tendons. Victorian Institute of Sport Tendon Study Group. Clin J Sport Med 8(2):73–77PubMed


Cook JL, Khan KM, Purdam C (2002) Achilles tendinopathy. Man Ther 7(3):121–130PubMed


Cook JL, Kiss ZS, Ptasznik R, Malliaras P (2005a) Is vascularity more evident after exercise? Implications for tendon imaging. AJR Am J Roentgenol 185(5):1138–1140. doi:10.​2214/​AJR.​04.​1205 PubMed


Couppe C, Hansen P, Kongsgaard M, Kovanen V, Suetta C, Aagaard P et al (2009) Mechanical properties and collagen cross-linking of the patellar tendon in old and young men. J Appl Physiol (1985) 107(3):880–886. doi:10.​1152/​japplphysiol.​00291.​2009


Crossley KM, Thancanamootoo K, Metcalf BR, Cook JL, Purdam CR, Warden SJ (2007) Clinical features of patellar tendinopathy and their implications for rehabilitation. J Orthop Res 25(9):1164–1175. doi:10.​1002/​jor.​20415 PubMed

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Sep 6, 2017 | Posted by in ORTHOPEDIC | Comments Off on Pathophysiology of Tendinopathy

Full access? Get Clinical Tree

Get Clinical Tree app for offline access